MedPath
TGA Approval

YERVOY ipilimumab (rch) 200mg in 40mL (5mg/mL) concentrate solution for IV infusion vial (174322)

174322

YERVOY ipilimumab (rch) 200mg in 40mL (5mg/mL) concentrate solution for IV infusion vial

Bristol-Myers Squibb Australia Pty Ltd

July 4, 2011

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/2d6ccf0b75159c0a76df520ab879c578.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/3182b6de425ac8d57e180b5f6d4c40fb.pdf

Active Ingredients

Ipilimumab

© Copyright 2025. All Rights Reserved by MedPath